Abstract:Background: Early diagnosis is critical to reduce the mortality caused by nasopharyngeal carcinoma (NPC). MicroRNAs (miRNAs) are dysregulated and play important roles in carcinogenesis. Therefore, this study aimed to identify diagnostically relevant circulating miRNA signatures in patients with NPC. Methods: Total RNA was extracted from whole blood samples obtained from 120 patients with NPC, 30 patients with head-neck tumors (HNT), and 30 healthy subjects (HSs), and examined by using a custom microarray. The expression levels of four miRNAs identified by using the microarray were validated with quantitative real-time reverse transcription polymerase chain reaction. The 120 patients with NPC and 30 HSs were randomly assigned to training group-1 and validation group-1, respectively. By using significance analysis of microarray (SAM), the specific miRNA expression profiles in whole blood from patients with NPC are obtained. By using lasso regression and adaptive boosting, a diagnostic signature was identified in training group-1, and its accuracy was verified in validation group-1. By using the same methods, another signature to distinguish patients with NPC from those with HNT and HSs was identified in training group-2 and confirmed in validation group-2. Results: There were 117 differentially expressed miRNAs (upregulated and downregulated fold change ≥ 1.5) between the patients with NPC and HSs, among which an 8-miRNA signature was identified with 96.43% sensitivity and 100% specificity [area under the curve (AUC) = 0.995] to diagnose NPC in training group-1 and 86.11% sensitivity and 88.89% specificity (AUC = 0.941) in validation group-1. Compared with traditional Epstein-Barr virus (EBV) seromarkers, this signature was more specific for NPC. Furthermore, a 16-miRNA signature to differentiate NPC from HNT and HS (HNT-HS) was established from 164 differentially expressed miRNAs, which diagnosed NPC and HNT-HS with 100% accuracy (AUC = 1.000) in training group-2 and 87.04% (AUC = 0.924) in validation group-2. Conclusions: The present study identified two miRNA signatures for the highly accurate diagnosis and differential diagnosis of patients with NPC from HSs and patients with HNT. The identified miRNAs might represent novel serological biomarkers and potential therapeutic targets for NPC.

Identification of Candidate Biomarkers for the Early Detection of Nasopharyngeal Carcinoma by Quantitative Proteomic Analysis.

Identification of Prognostic Biomarkers for Response to Radiotherapy by DNA Microarray in Nasopharyngeal Carcinoma Patients

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma

Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis

SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma

[A pilot investigation on serum protein fingerprinting of nasopharyngeal carcinoma]

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis

A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis

Autoantibody Signatures as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma

Detection of Serum Protein Biomarkers by Surface Enhancedlaser Desorption Ionization Time of Flight Mass Spectrometry in Patients of Nasopharyngeal Carcinoma

[A study of the indications for and results of speech reeducation in children].

A Cross-Cultural Study of the Attitudes of Mental Health Professionals Towards Auditory Hallucinations

Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis

Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection

Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis

Lipid digestion and absorption in early life: an update

The Re-Emergence of Core Region Growth: A Return to the Metropolis?

Gene-specific changes in induced enzyme synthesis in Escherichia coli infected with phage pX174.

Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma

Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma

Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis